Android app Apple app link

BofA Raises Teva Pharmaceutical (TEVA) PT to $24, Amid "Pivot to Growth" Strategy Execution

By Yahoo! Finance   |   1 month ago
BofA Raises Teva Pharmaceutical (TEVA) PT to $24, Amid "Pivot to Growth" Strategy Execution

Teva Pharmaceutical Industries (NYSE: TEVA) stock is promising under $100, with BofA raising price target to $24. Teva saw revenue growth in Q2 2025, targeting a 30% profit margin by 2027.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.